Close

UPDATE: KeyBanc Starts Figs Inc. (FIGS) at Overweight

Go back to UPDATE: KeyBanc Starts Figs Inc. (FIGS) at Overweight

Analysts Mostly Positive in New Coverage on Figs (FIGS), a 'Credible Disruptor With Outsized Growth Potential' Says Analyst

June 21, 2021 9:27 AM EDT

Wall Street analysts are leaning positive in new coverage on Figs (NYSE: FIGS), with eight out of ten analysts starting at a Buy rating or equivalent. On the other side, analysts from Goldman Sachs and Morgan Stanley are neutral. Shares of the company are up 2.3% on the day.

Medical apparel and scrubs company Figs debuted on the New York Stock Exchange (NYSE) to see its shares soar by 36% on the first day of trading in May.

The company priced its stock at $22 per share, which is by $3 more than the expected... More

UPDATE: Goldman Sachs Starts Figs Inc. (FIGS) at Neutral

June 21, 2021 3:25 AM EDT

(Updated - June 21, 2021 4:19 AM EDT)

Goldman Sachs analyst Kate McShane initiates coverage on Figs Inc. (NYSE: FIGS) with a Neutral rating and a price target of $28.00.

The analyst comments "We see FIGS as a unique high-growth digitally native brand that is... More

UPDATE: Morgan Stanley Starts Figs Inc. (FIGS) at Equalweight

June 21, 2021 3:10 AM EDT

(Updated - June 21, 2021 4:20 AM EDT)

Morgan Stanley analyst Lauren Schenk initiates coverage on Figs Inc. (NYSE: FIGS) with a Equalweight rating and a price target of $34.00.

The analyst comments "FIGS has disrupted a previously commoditized scrubs industry, building a premium,... More